Abstract: A method may include receiving a registration request at a server of a consent management platform from a content-presentation device, and using an authentication certificate in the request to establish a secure communicative connection. The server may generate: a global ID (GID) from information received over the secure connection; a device-based device record for the device, and including the GID and a unique address indicator; and a cryptographically-signed token. The GID, device record, and token may be transmitted to the device. The unique address indicator may be associated with consent packages having features of a media distribution system that require user consent to associated agreements for activation on the device. The server may generate a server-based device record duplicating the device-based device record, and including the consent packages and indicators of consent agreement status initialized to undeclared. The server may store the server-based device record in a flat database.

Abstract: A system comprising a vaporizing device and a central server is described. The vaporizing device includes a housing and a cartridge, received within the housing, the cartridge including a predefined quantity of concentrate and an identification code associated with the concentrate and uniquely identifying the cartridge. The vaporizing device further includes a control unit configured to read the identification code. The vaporizing device further includes a communication unit configured to transmit the identification code to a computing device of a user. The central server includes a database. The central server is configured to receive the identification code from the computing device and retrieve concentrate information corresponding to the identification code from the database. The central server is configured to transmit the concentrate information to the computing device for displaying to the user.

Abstract: Media processing systems and techniques are described. A media processing system receives image data that represents an environment captured by an image sensor. The media processing system receives an indication of an object in the environment that is represented in the image data. The media processing system divides the image data into regions, including a first region and a second region. The object is represented in one of the plurality of regions. The media processing system modifies the image data to obscure the first region without obscuring the second region based on the object being represented in the one of the plurality of regions. The media processing system outputs the image data after modifying the image data. In some examples, the object is depicted in the first region and not the second region. In some examples, the object is depicted in the second region and not the first region.

Abstract: The present invention relates to deuterated and optionally detectably labeled compounds of formula (I) and formula (V): and salts thereof, wherein R1, R2, A, and X10-X19 have any of the values defined in the specification. Also included are pharmaceutical compositions comprising such compounds and salts, and methods of using such compounds and salts as imaging agents.

Abstract: Various embodiments include methods and devices for implementing a criterion aware cache replacement policy by a computing device. Embodiments may include updating a staling counter, writing a value of a local counter to a system cache in association with a location in the system cache for with data, in which the value of the local counter includes a value of the staling counter when (i.e., at the time) the associated data is written to the system cache, and using the value of the local counter of the associated data to determine whether the associated data is stale.

Abstract: Provided are CD8 binding agents comprising a VHH domain that specifically binds human CD8. Also provided are nucleic acids encoding such CD8 binding agents, vectors comprising such nucleic acids, host cells comprising same, and methods of making such CD8 binding agents. Also provided are CD8 binding agents having the VHH domain conjugated to a detectable label. Provided are methods of using such CD8 binding agents to detect CD8+ T cells, monitor disease progress, and monitor treatment progress in a subject having cancer, autoimmune disease or condition, transplant rejection or graft-versus-host disease.

Abstract: Systems, methods, and computer-readable media are provided for providing pose estimation in extended reality systems. An example method can include tracking, in a lower-power processing mode using a set of lower-power circuit elements on an integrated circuit, a position and orientation of a computing device during a lower-power processing period, the set of lower-power circuit elements including a static random-access memory (SRAM); suspending, based on a triggering event, the tracking in the lower-power processing mode; initiating a higher-power processing mode for tracking the position and orientation of the computing device during a higher-power processing period; and tracking, in the higher-power processing mode using a set of higher-power circuit elements on the integrated circuit and a dynamic random-access memory (DRAM), the position and orientation of the computing device during the higher-power processing period.

Abstract: The present invention relates to a 3?-ketoglycoside compound defined by formula (I) and its use for controlled release of alcohols, in particular alcohols showing an insect repellent effect. It relates also to a process for preparing the 3?-ketoglycoside compound of formula (I). It further relates to a composition comprising a 3?-ketoglycoside compound of formula (I). It relates also to the use of a 3?-ketoglycoside compound of formula (I) for the controlled release of alcohols. It related also to a method of use of such composition.

Abstract: Aspects of the invention include a wafer test device with a conformal laminate and rigid probes extending from the laminate to form an electrical connection with a microcircuit under test. The wafer test device also includes a spring plate on a side of the laminate that is opposite a side from which the rigid probes extend. The spring plate includes a conformal inner frame and a rigid outer frame. The laminate is attached to the inner frame of the spring plate.

Abstract: Aspects of the invention include a wafer test device with a conformal laminate and rigid probes extending from the laminate to form an electrical connection with a microcircuit under test. The wafer test device also includes a spring plate on a side of the laminate that is opposite a side from which the rigid probes extend. The spring plate includes a conformal inner frame and a rigid outer frame. The laminate is attached to the inner frame of the spring plate.

Abstract: A wafer test device includes a test interconnect to interface with a microcircuit of the wafer at a first side and an interposer to interface with the test interconnect at a second side of the test interconnect, opposite the first side. The interposer connects the test interconnect, via a printed circuit board (PCB), to a test apparatus that determines and controls test patterns that are applied to the microcircuit via the test interconnect. A support structure supports the test interconnect and the interposer. The support structure includes an inner bearing to tilt the test interconnect to match a tilt of a surface of the microcircuit. An elastomer between the test interconnect and the interposer reduces deflection of the test interconnect during a process of connecting the test interconnect to the microcircuit.

Abstract: A system comprising a vaporizing device and a central server is described. The vaporizing device includes a housing and a cartridge, received within the housing, the cartridge including a predefined quantity of concentrate and an identification code associated with the concentrate and uniquely identifying the cartridge. The vaporizing device further includes a control unit configured to read the identification code. The vaporizing device further includes a communication unit configured to transmit the identification code to a computing device of a user. The central server includes a database. The central server is configured to receive the identification code from the computing device and retrieve concentrate information corresponding to the identification code from the database. The central server is configured to transmit the concentrate information to the computing device for displaying to the user.

Abstract: A system architecture for operation of aircraft flaps. The system architecture includes a first pair of motor drive units, the first pair comprising a first motor drive unit (MD1) and a second motor drive unit (MD3), and a second pair of motor drive units, the second pair comprising a third motor drive unit (MD2) and a fourth motor drive unit (MD4). The system further includes a first plurality of switches connected between the first motor drive unit (MD1) and the second motor drive unit (MD3), the first plurality of switches configured to operate a first electric motor and a second electric motor, and a second plurality of switches connected between the third motor drive unit (MD2) and the fourth motor drive unit (MD4), the second plurality of switches configured to operate a third electric motor and a fourth electric motor.

Abstract: A system architecture for a backup thrust reverser actuation system control is provided. The system architecture includes an AC power supply of an aircraft, a power supply and a motor control adapted to control an electric motor (M) of a thrust reverser actuation system.

Abstract: A method of treating HIV comprising intramuscular administration once every 4 weeks or less frequently of a combination of cabotegravir or a pharmaceutically acceptable salt thereof and rilpivirine or a pharmaceutically acceptable salt thereof, including the option of discontinuing administration of a first oral anti-retroviral regimen and intramuscularly administering, once four weeks or less often said combination of cabotegravir and rilpivirine.

Abstract: A method for producing conductive materials from Nb-doped TiO2-particles, in which Nb-doped TiO2-particles are pressed to form bodies and the bodies are treated in an oxygen-containing atmosphere and at a reducing atmosphere.

Abstract: In a dosage system for delivering a predetermined amount and type of cleaning concentrate to a solvent inside a fluid tank, a pod holder is configured to form an inner volume for holding a pod containing the cleaning concentrate. A connector is configured to form a fluid connection between the inner volume of the pod holder and the inside of the fluid tank. A piercing device is configured to pierce the pod held by the pod holder. A push mechanism is configured to push the piercing device into the inner volume of the pod holder for piercing the pod to release the cleaning concentrate from the pod via the fluid connection of the connector into the inside of the fluid tank.

Abstract: A wafer test device includes a test interconnect to interface with a microcircuit of the wafer at a first side and an interposer to interface with the test interconnect at a second side of the test interconnect, opposite the first side. The interposer connects the test interconnect, via a printed circuit board (PCB), to a test apparatus that determines and controls test patterns that are applied to the microcircuit via the test interconnect. A support structure supports the test interconnect and the interposer. The support structure includes an inner bearing to tilt the test interconnect to match a tilt of a surface of the microcircuit. An elastomer between the test interconnect and the interposer reduces deflection of the test interconnect during a process of connecting the test interconnect to the microcircuit.

Abstract: Methods, systems, and apparatus, including computer programs encoded on computer storage media, for generating data specifying a three-dimensional mesh of an object using an auto-regressive neural network.

Abstract: A computer-implemented method, in which an access request in relation to data is received. There is Error Correcting Code (ECC) data relating to the data, and the ECC data is configured to enable correction of multiple-bit errors spanning up to a predetermined number of consecutive bits of the data. The ECC data is configured to enable correction of multiple-bit errors spanning up to a predetermined number of consecutive bits of the data. A first integrity verification verifies the integrity of at least the data. If the first integrity verification procedure fails, an error analysis procedure is performed based on the data and the ECC data. Responsive to generation of corrected data by the error analysis procedure, a second integrity verification verifies the integrity of the corrected data. If the second integrity verification is successful, the access request is allowed using the corrected data.